| Anderson, Peter |
| Completed | 2/3 | 54 | RoW | co-formulated 25mg TAF/ 200mg FTC, Descovy | University of Washington, Kenya Medical Research Institute, University of Colorado, Denver, Gilead Sciences | HIV Infections | 12/23 | 12/23 | | |
NCT06435026: Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1 |
|
|
| Recruiting | 2 | 54 | RoW | FTC/TDF 200mg/300mg, PrEP, FTC/TDF 300mg/450mg, FTC/TDF 400mg/600mg | University of North Carolina, Chapel Hill, National Institute of Allergy and Infectious Diseases (NIAID) | HIV, Prevention, Pregnancy | 02/25 | 02/25 | | |
| Active, not recruiting | 2 | 72 | RoW | co-formulated 300 mg TDF/ 200mg FTC, Truvada | University of Washington, University of Colorado, Denver, Kenya Medical Research Institute, National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 01/25 | 01/25 | | |
| Completed | N/A | 15 | US | Adenine 5+ (five stable-labeled nitrogens), taggant | University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID) | Healthy | 11/22 | 11/22 | | |
| Active, not recruiting | N/A | 384 | US | | University of Colorado, Denver | Hiv | 05/25 | 05/25 | | |
NCT04065347: Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF) |
|
|
| Completed | N/A | 84 | US | Digital Pill, etectRx ID-Cap System | University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID) | HIV/AIDS, Adherence, Medication | 05/23 | 05/23 | | |
HOME-1, NCT04979728: HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots |
|
|
| Recruiting | N/A | 150 | US | At Home Self-Collections, Tasso-M20, Tasso+, Mitra, DBS by fingerstick | University of Colorado, Denver, National Institute of Allergy and Infectious Diseases (NIAID) | HIV Treatment, HIV Prevention | 12/25 | 12/25 | | |
| Kaufman, Carol E |
| Completed | N/A | 439 | US | Native WYSE CHOICES | University of Colorado, Denver, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Exposed Pregnancy | 02/24 | 02/24 | | |
| Erlandson, Kristine |
| Completed | 3 | 602 | US | Pitavastatin, Placebos | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Aging (NIA) | HIV-1 Infection | 08/23 | 08/23 | | |
NCT04216589: Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) |
|
|
| Completed | 2 | 51 | US, RoW | Semaglutide | National Institute of Allergy and Infectious Diseases (NIAID), The University of Texas Health Science Center, Houston | HIV Infections, Non-Alcoholic Fatty Liver Disease | 03/23 | 09/23 | | |
| Active, not recruiting | 2 | 51 | US, RoW | Semaglutide | AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (NIAID) | HIV-1-infection, Adiposity, Insulin Resistance, Pre-diabetes, Hepatic Steatosis | 08/23 | 08/23 | | |
| Recruiting | 2 | 380 | US | IVIG + Coordinated Care, IVIG Placebo + Coordinated Care, Ivabradine + Coordinated Care, Ivabradine Placebo + Coordinated Care, IVIG + Usual Care, IVIG Placebo + Usual Care, Ivabradine + Usual Care, Ivabradine Placebo + Usual Care | Kanecia Obie Zimmerman | Long COVID, Long Covid19, Long Covid-19 | 12/25 | 03/26 | | |
| Recruiting | 2 | 1074 | US | Modafinil, Modafinil Placebo, Solriamfetol, Solriamfetol Placebo, Melatonin, Melantonin Placebo, Tailored lighting (TL) Active, Tailored lighting (TL) Placebo | Duke University | Long COVID, Long COVID-19, Hypersomnia, Sleep Disturbance | 07/25 | 07/25 | | |
| Not yet recruiting | 2 | 100 | US | Tesamorelin, Egrifta, TH9507, growth hormone-releasing hormone analogue, Placebo, Exercise | Massachusetts General Hospital, University of Colorado - Anschutz Medical Campus | HIV-1-infection, Frailty, Impaired Physical Function, Abdominal Obesity, Aging | 03/28 | 09/28 | | |
NCT04495348: Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance |
|
|
| Completed | N/A | 18 | US | Doravirine | University of Colorado, Denver, Gilead Sciences | HIV-1-infection, Weight Gain | 01/23 | 06/23 | | |
NCT05172024: Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) |
|
|
| Active, not recruiting | N/A | 15178 | US | | NYU Langone Health, National Heart, Lung, and Blood Institute (NHLBI) | SARS-CoV2 Infection | 04/25 | 05/25 | | |
NCT04550676: High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV |
|
|
| Active, not recruiting | N/A | 118 | US | HIIT (intervention), CME (active control) | University of Colorado, Denver, Case Western Reserve University, University of Washington | Hiv, Fatigue, Mobility Limitation | 07/25 | 12/25 | | |
HEALTH-COG, NCT06013579: Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV |
|
|
| Recruiting | N/A | 110 | US | Phase 1 Gym Exercise HIIT, Phase 1 Gym Exercise CME, Phase 2 Home Exercise Coaching Text Messages, Phase 2 Home Exercise Control Text Messages | University of Alabama at Birmingham, University of Colorado, Denver, University of Washington, National Institute on Aging (NIA) | HIV Infections, Cognitive Impairment | 09/27 | 03/28 | | |
| Forman, Lisa |
NCT01846663: Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy |
|
|
| Terminated | 4 | 6 | US | Placebo, Rifaximin, XIFAXAN® Tablets | Bausch Health Americas, Inc. | Hepatic Encephalopathy | 02/16 | 02/16 | | |
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) |
|
|
| Recruiting | 2 | 200 | Europe, Canada, US, RoW | Volixibat, SHP626, Placebo | Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc. | Primary Sclerosing Cholangitis | 09/25 | 12/25 | | |
NCT05569759: A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) |
|
|
| Active, not recruiting | 2 | 24 | US | zetomipzomib, KZR-616, placebo, sterile water for injection, zetomipzomib in open-label extension | Kezar Life Sciences, Inc. | Autoimmune Hepatitis | 02/25 | 08/25 | | |
NCT06699121: A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC |
|
|
| Not yet recruiting | 2 | 87 | US | LB-P8 low-dose, LB-P8 high-dose, Placebo | LISCure Biosciences | Primary Sclerosing Cholangitis (PSC) | 03/28 | 02/29 | | |
| Boimbo, Sandra |
NCT04404101: Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies |
|
|
| Recruiting | N/A | 300 | US | 1). EUS-FNA plus MFB, 2). EUS-FNA Alone | University of Colorado, Denver, US Endoscopy | Pancreatic Cyst | 04/25 | 04/25 | | |
| Recruiting | N/A | 5000 | US | | University of Colorado, Denver, University of Chicago, University of Kansas, University of Pennsylvania, Johns Hopkins University, City of Hope National Medical Center, Loma Linda University, MedStar Georgetown, University of Arizona, University of Manitoba, University of Michigan, University of North Carolina, University of Pittsburgh, University of Rochester, Dana-Farber Cancer Institute, University of Wisconsin, Madison, The Cleveland Clinic, University of California, San Diego, Kaiser Permanente, Ohio State University, Virginia Mason Hospital/Medical Center, University of Alabama at Birmingham, University of Miami | Lynch Syndrome | 12/54 | 12/54 | | |
SWAT-BE, NCT05530343: Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance |
|
|
| Recruiting | N/A | 2298 | US | Seattle protocol, WATS3D brushings | University of Colorado, Denver | Barrett Esophagus, Barretts Esophagus With Dysplasia, Esophageal Adenocarcinoma | 03/26 | 03/26 | | |
SURVENT, NCT05753748: Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia |
|
|
| Recruiting | N/A | 680 | US | Endoscopic Eradication Therapy | University of Colorado, Denver, Baylor University, University of North Carolina, Medical University of South Carolina, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Barretts Esophagus With Dysplasia, Barrett Esophagus, Esophageal Adenocarcinoma | 02/28 | 02/28 | | |
| Stites, Erik |
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry |
|
|
| Active, not recruiting | N/A | 4000 | US | Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox) | CareDx | Kidney Transplant Rejection | 06/25 | 12/25 | | |
| Active, not recruiting | N/A | 5000 | US | Prospera | Natera, Inc., University of Maryland | Kidney Transplant Rejection | 10/26 | 10/27 | | |
| Kornfeld, Lisa |
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry |
|
|
| Active, not recruiting | N/A | 4000 | US | Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox) | CareDx | Kidney Transplant Rejection | 06/25 | 12/25 | | |
| Sarche, Michelle |
| Completed | N/A | 439 | US | Native WYSE CHOICES | University of Colorado, Denver, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Exposed Pregnancy | 02/24 | 02/24 | | |
| Shrestha, Umit |
| Completed | N/A | 439 | US | Native WYSE CHOICES | University of Colorado, Denver, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Exposed Pregnancy | 02/24 | 02/24 | | |
| Oser, Tamara K |
NCT04600622: Adapting and Assessing the Feasibility of a Diabetes Self-management Telehealth Intervention |
|
|
| Completed | N/A | 67 | US | Rural Diabetes One-Day Education and Care program (R-D1D), Diabetes Education Materials | University of Utah, University of Colorado, Denver | Diabetes Mellitus | 04/22 | 08/22 | | |
NCT05168657: Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth |
|
|
| Completed | N/A | 54 | US | Bionic Pancreas, BP, Usual Care, UC | University of Colorado, Denver, Beta Bionics, Inc., Massachusetts General Hospital | Diabetes Mellitus, Type 1, Type 1 Diabetes, Diabetes, Autoimmune, Diabetes type1, Autoimmune Diabetes, Diabetes Mellitus, Brittle, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent, 1, Diabetes Mellitus, Juvenile-Onset, Diabetes Mellitus, Ketosis-Prone, Diabetes Mellitus, Sudden-Onset, Insulin-Dependent Diabetes Mellitus 1, Juvenile-Onset Diabetes, Type 1 Diabetes Mellitus | 05/23 | 05/23 | | |
| Completed | N/A | 40 | US | GEM, Routine Care | University of Colorado, Denver, Abbott Diabetes Care, University of Virginia | PreDiabetes | 01/25 | 01/25 | | |
| Completed | N/A | 343 | US | Omnipod 5 Automated Glucose Control System | Insulet Corporation, Jaeb Center for Health Research | Type2 Diabetes | 03/24 | 03/24 | | |
| Completed | N/A | 190 | US | Virtual CGM initiation service, Online educational module on CGM, Practice facilitation | University of Colorado, Denver, The Leona M. and Harry B. Helmsley Charitable Trust | Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Continuous Glucose Monitoring | 11/24 | 11/24 | | |
GEM, NCT05766735: Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: a Paradigm Shift in Lifestyle Modification |
|
|
| Recruiting | N/A | 200 | US | Routine Care + Glycemic Excursion Minimization (RC+GEM), Glucose Everyday Matters, Routine Care (RC) | Chiara Fabris, PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), DexCom, Inc. | Type 2 Diabetes | 01/27 | 01/27 | | |
| Prince, Britney |
| Completed | N/A | 40 | US | GEM, Routine Care | University of Colorado, Denver, Abbott Diabetes Care, University of Virginia | PreDiabetes | 01/25 | 01/25 | | |
GEM, NCT05766735: Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: a Paradigm Shift in Lifestyle Modification |
|
|
| Recruiting | N/A | 200 | US | Routine Care + Glycemic Excursion Minimization (RC+GEM), Glucose Everyday Matters, Routine Care (RC) | Chiara Fabris, PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), DexCom, Inc. | Type 2 Diabetes | 01/27 | 01/27 | | |
| Steele, Cortney |
EXPLORE, NCT06496542: Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD |
|
|
| Recruiting | N/A | 20 | US | Daily caloric restriction, Standard advice control | University of Colorado, Denver, Nutrition Obesity Research Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Autosomal Dominant Polycystic Kidney | 01/26 | 01/26 | | |
